MX9207687A - Compuestos intermedios para la preparacion de acidos oxoftalazinil aceticos. - Google Patents

Compuestos intermedios para la preparacion de acidos oxoftalazinil aceticos.

Info

Publication number
MX9207687A
MX9207687A MX9207687A MX9207687A MX9207687A MX 9207687 A MX9207687 A MX 9207687A MX 9207687 A MX9207687 A MX 9207687A MX 9207687 A MX9207687 A MX 9207687A MX 9207687 A MX9207687 A MX 9207687A
Authority
MX
Mexico
Prior art keywords
preparation
acids
acetic acids
oxoftalazinyl
intermediate compounds
Prior art date
Application number
MX9207687A
Other languages
English (en)
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9207687A publication Critical patent/MX9207687A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención se refiere a compuestos intermedios para la preparación de ácidos oxoftalazinil acético con cadenas laterales de benzotiazol por reacción de un acetato de oxoftalaziniltioacetamida con sulfuro de hidrógeno y un compuesto nitrofenílico que contiene un grupo reactivo de manera que pueda formarse la cadena lateral de benzotiazol por ciclación en la que interviene el grupo tioacetamido. La oxoftalaziniltioacetamida puede ser preparada por reacción del correspondiente acetato de cianometiloxoftalazinilo con sulfuro de hidrógeno en presencia de aminas terciarias. Loa ácidos imizadol y oxopirido-pirida-zinonacéticos análogos pueden ser preparados de forma similar, así como los ácidos oxoftalazinil-, indazol- y oxopiridopiridazinon-acéticos con cadenas laterales de tiazolopiridinilo.
MX9207687A 1989-05-11 1992-12-31 Compuestos intermedios para la preparacion de acidos oxoftalazinil aceticos. MX9207687A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,997 US4954629A (en) 1989-05-11 1989-05-11 Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Publications (1)

Publication Number Publication Date
MX9207687A true MX9207687A (es) 1994-06-30

Family

ID=23379152

Family Applications (2)

Application Number Title Priority Date Filing Date
MX020672A MX167455B (es) 1989-05-11 1990-05-11 Procedimiento para la preparacion de acidos oxoftalazinil aceticos
MX9207687A MX9207687A (es) 1989-05-11 1992-12-31 Compuestos intermedios para la preparacion de acidos oxoftalazinil aceticos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX020672A MX167455B (es) 1989-05-11 1990-05-11 Procedimiento para la preparacion de acidos oxoftalazinil aceticos

Country Status (30)

Country Link
US (1) US4954629A (es)
EP (1) EP0397350B1 (es)
JP (1) JPH035479A (es)
KR (1) KR920006419B1 (es)
CN (1) CN1025855C (es)
AR (1) AR246968A1 (es)
AT (1) ATE103913T1 (es)
AU (2) AU618898B2 (es)
BG (1) BG50609A3 (es)
CA (1) CA2016504C (es)
CZ (1) CZ281213B6 (es)
DD (1) DD294257A5 (es)
DE (1) DE69007846T2 (es)
DK (1) DK0397350T3 (es)
EG (1) EG19082A (es)
ES (1) ES2063265T3 (es)
FI (1) FI93959C (es)
HU (1) HU212304B (es)
IE (1) IE62591B1 (es)
IL (3) IL114271A (es)
MX (2) MX167455B (es)
NO (1) NO177708C (es)
NZ (1) NZ233597A (es)
PH (1) PH26567A (es)
PL (1) PL164427B1 (es)
PT (1) PT93985B (es)
RO (1) RO107256B1 (es)
RU (1) RU2014333C1 (es)
YU (1) YU91290A (es)
ZA (1) ZA903565B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
EP3192796B1 (en) * 2010-07-16 2019-09-04 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and uses thereof
CN102558184B (zh) * 2011-12-30 2014-07-16 西南大学 酞嗪类衍生物的合成方法
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
DK3352754T3 (da) 2016-06-21 2020-12-07 Univ Columbia Aldosereduktaseinhibitorer og fremgangsmåder til anvendelse deraf
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
CN113840825A (zh) 2019-04-01 2021-12-24 应用治疗公司 醛糖还原酶抑制剂
WO2020227430A1 (en) 2019-05-07 2020-11-12 University Of Miami Treatment and detection of inherited neuropathies and associated disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
DE3337859A1 (de) * 1983-01-21 1984-07-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von benzthiazolen
CA1299178C (en) * 1985-11-07 1992-04-21 Banavara Lakshmana Mylari Heterocyclic oxophtalazinyl acetic acids
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Also Published As

Publication number Publication date
CZ227890A3 (en) 1996-04-17
FI93959B (fi) 1995-03-15
PT93985A (pt) 1991-01-08
PT93985B (pt) 1996-11-29
IL114271A0 (en) 1995-10-31
IL114271A (en) 1998-04-05
RO107256B1 (ro) 1993-10-30
HU902995D0 (en) 1990-09-28
AR246968A1 (es) 1994-10-31
AU626225B2 (en) 1992-07-23
CN1047499A (zh) 1990-12-05
JPH035479A (ja) 1991-01-11
ATE103913T1 (de) 1994-04-15
YU91290A (sh) 1992-09-07
PH26567A (en) 1992-08-19
US4954629A (en) 1990-09-04
DD294257A5 (de) 1991-09-26
AU8680691A (en) 1992-01-02
KR900018114A (ko) 1990-12-20
EG19082A (en) 1994-07-30
KR920006419B1 (ko) 1992-08-06
PL164427B1 (pl) 1994-07-29
NO902071L (no) 1990-11-12
DE69007846D1 (de) 1994-05-11
IE901626L (en) 1990-11-11
NO177708B (no) 1995-07-31
ZA903565B (en) 1991-12-24
CA2016504A1 (en) 1990-11-11
PL285113A1 (en) 1991-07-15
DE69007846T2 (de) 1994-07-28
IL94301A (en) 1996-01-19
IL94301A0 (en) 1991-03-10
ES2063265T3 (es) 1995-01-01
DK0397350T3 (da) 1994-05-09
BG50609A3 (en) 1992-09-15
CZ281213B6 (cs) 1996-07-17
NZ233597A (en) 1992-02-25
CN1025855C (zh) 1994-09-07
EP0397350A1 (en) 1990-11-14
FI902333A0 (fi) 1990-05-10
IE62591B1 (en) 1995-02-08
FI93959C (fi) 1995-06-26
HUT54690A (en) 1991-03-28
HU212304B (en) 1996-05-28
JPH0573753B2 (es) 1993-10-15
EP0397350B1 (en) 1994-04-06
CA2016504C (en) 1999-07-27
AU5490690A (en) 1990-11-15
NO177708C (no) 1995-11-08
MX167455B (es) 1993-03-23
AU618898B2 (en) 1992-01-09
NO902071D0 (no) 1990-05-10
RU2014333C1 (ru) 1994-06-15

Similar Documents

Publication Publication Date Title
MX9207687A (es) Compuestos intermedios para la preparacion de acidos oxoftalazinil aceticos.
IL72966A0 (en) Process for the preparation of insulin derivatives,the b chain of which is lengthened c-terminally,novel insulin derivatives modified by bases,agents containing these derivatives and their use
ES2155872T3 (es) Triestannoxanos.
JPS5399320A (en) Method for preparing aintigens
ATE61351T1 (de) Verfahren zur herstellung von schwefelverbindungen.
ES8705442A1 (es) Un procedimiento para preparar compuestos de carbapenem
JPS5681523A (en) Manufacture of benzene derivatives by reaction of activated halogenobenzene with anionic organic oxygenncontaining or sulfurrcontaining reactant
GB2042513B (en) Intermediates useful in the synthesis of chemiluminescent naphthalene-1,2-dicarboxylic acid hydrazide-labelled conjugates
ES8107203A1 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
GB2025408B (en) Process for the production of tertiary amine having long chain alkyl group
ATE26434T1 (de) Herstellung von trimangantetroxid.
DE69110837D1 (de) Verfahren zum Herstellen von Merkaptopropionsäureestern.
NO913769L (no) Forbindelse, fremstilling og anvendelse.
SE7610217L (sv) Kristallint dipilokarpiniumpamoat
GR3004764T3 (es)
EP0115314A3 (en) Process for the preparation of cholecalciferol derivatives
GB1206359A (en) Method for production of aminoalkyl fumarates
JPS51130402A (en) A method for manufacturing coal briquette
GB1005170A (en) Improvements in and relating to sprocket wheels for chain conveyors
ES485304A1 (es) Procedimiento para la preparacion de las benzotiazol-sulfe- namidas
JPS52111539A (en) Preparation of p-nitrophenylchloroformates
ES451091A1 (es) Procedimiento para la produccion del compuesto s 11743na en forma de acido.
IT8409364A0 (it) Macchina per la produzione dicatene ornamentali,in particolare di tipo accoppiato
ES8502730A1 (es) Procedimiento para preparar el acido o-b d-glucuronico de un compuesto que tiene un alcohol primario.
GB1530533A (en) Sulphenamides their production and their use as vulcanisation retarders

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees